ARS Pharmaceuticals
SPRY
SPRY
74 hedge funds and large institutions have $287M invested in ARS Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 36 increasing their positions, 12 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
-2
Holders Change %
-2.63%
% of All Funds
1.3%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
19
Increased
36
Reduced
12
Closed
20
Calls
–
Puts
$136K
Net Calls
-$136K
Net Calls Change
-$136K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$9.52M |
| 2 |
WA
2
Wasatch Advisors
Salt Lake City,
Utah
|
$14.3M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$16.7M |
| 4 |
4
Morgan Stanley
New York
|
$6.37M |
| 5 |
5
BlackRock
New York
|
$12.3M |
